LTHM / Livent Corporation - Depositi SEC, Relazione annuale, dichiarazione di delega

LTHM / Livent Corporation / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SC 13G/A 1 tv01358-liventcorp.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 5)* Name of issuer: Livent Corp Title of Class of Securities: Common Stock CUSIP Number: 53814L108 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to designate the rule pu

LTHM / Livent Corporation / WELLINGTON MANAGEMENT GROUP LLP - SEC SCHEDULE 13G Passive Investment

SC 13G 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Livent Corp. (Name of Issuer) Common Stock (Title of Class of Securities) 53814L108 (CUSIP Number) December 29, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate

LTHM / Livent Corporation / BlackRock Inc. Passive Investment

SC 13G/A 1 us53814l1089012324.txt us53814l1089012324.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 4) LIVENT CORPORATION - (Name of Issuer) Common Stock - (Title of Class of Securities) 53814L108 - (CUSIP Number) December 31, 2023 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 001-38694 LIVENT CORPORATION* (Exact name of registrant as specified in its

EX-99.25

NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES The New York Stock Exchange hereby notifies the SEC of its intention to remove the entire class of the stated securities from listing and registration on the Exchange at the opening of business on January 22, 2024, pursuant to the provisions of Rule 12d2-2 (a).

LTHM / Livent Corporation / ICS OPPORTUNITIES, LTD. Passive Investment

SC 13G 1 LTHMSC13G.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 LIVENT CORPORATION (Name of Issuer) COMMON STOCK, PAR VALUE $0.001 PER SHARE (Title of Class of Securities) 53814L108 (CUSIP Number) DECEMBER 29, 2023 (Date of event which requires filing of this statement) Check the appropriate box to designate the

As filed with the Securities and Exchange Commission on January 4, 2024

As filed with the Securities and Exchange Commission on January 4, 2024 Registration No.

AMENDED AND RESTATED BYLAWS OF LIVENT CORPORATION * * * * * As of January 4, 2024 Article 1 Offices

Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF LIVENT CORPORATION * * * * * As of January 4, 2024 Article 1 Offices Section 1.01. Registered Office. The registered office of the Corporation shall be in the City of Wilmington, County of New Castle, State of Delaware. Section 1.02. Other Offices. The Corporation may also have offices at such other places both within and without the State of Delaware as

As filed with the Securities and Exchange Commission on January 4, 2024

As filed with the Securities and Exchange Commission on January 4, 2024 Registration No.

As filed with the Securities and Exchange Commission on January 4, 2024

As filed with the Securities and Exchange Commission on January 4, 2024 Registration No.

JOINDER AND FIRST AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT

Exhibit 10.2 Execution Version JOINDER AND FIRST AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT JOINDER AND FIRST AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT (this “Amendment”), dated as of January 4, 2024, by and among ARCADIUM LITHIUM PLC, a public limited company incorporated under the laws of the Bailiwick of Jersey with registration number 148645 (“Arcadium”), ARCADIUM LITHIUM INTE

As filed with the Securities and Exchange Commission on January 4, 2024

As filed with the Securities and Exchange Commission on January 4, 2024 Registration No.

FIRST SUPPLEMENTAL INDENTURE

Exhibit 4.2 FIRST SUPPLEMENTAL INDENTURE FIRST SUPPLEMENTAL INDENTURE (this “Supplemental Indenture”), dated as of January 4, 2024, by and among ARCADIUM LITHIUM PLC, a public limited company incorporated under the laws of the Bailiwick of Jersey (“NewCo”), LIVENT CORPORATION, a Delaware corporation (the “Company”), and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION (as successor-in-interest to U.S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 4, 2024 LIVENT CORPORATIO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 4, 2024 LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorporation or organization)

As filed with the Securities and Exchange Commission on January 4, 2024

As filed with the Securities and Exchange Commission on January 4, 2024 Registration No.

As filed with the Securities and Exchange Commission on January 4, 2024

As filed with the Securities and Exchange Commission on January 4, 2024 Registration No.

AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF LIVENT CORPORATION * * *

Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF LIVENT CORPORATION * * * FIRST: The name of the corporation is Livent Corporation (the “Corporation”). SECOND: The address of its registered office in the State of Delaware is 251 Little Falls Drive, City of Wilmington, County of New Castle, Delaware 19808. The name of its registered agent at such address is Corporation Service Compa

Third Amendment to Transaction Agreement, dated as of December 20, 2023, by and between Livent Corporation, and Allkem Limited, an Australian public company limited by shares (Exhibit 2.1 to Livent's Current Report on Form 8-K filed on December 27, 2023)

Exhibit 2.1 THIRD AMENDMENT TO TRANSACTION AGREEMENT This THIRD AMENDMENT TO TRANSACTION AGREEMENT (this “Amendment”), dated as of December 20, 2023, is by and between Livent Corporation, a Delaware corporation (“Livent”), and Allkem Limited, an Australian public company limited by shares (“Allkem”). Each of Livent and Allkem are referred to as a “Party,” and collectively, as the “Parties.” WHEREA

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 27, 2023 (December 20, 2

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 27, 2023 (December 20, 2023) LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorpora

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 20, 2023 (December 15, 2

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 20, 2023 (December 15, 2023) LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorpora

Livent and Allkem Shareholders Approve Merger of Equals

Exhibit 99.1 Livent and Allkem Shareholders Approve Merger of Equals December 19, 2023 PHILADELPHIA, December 19, 2023 – Livent Corporation (NYSE: LTHM, “Livent”) and Allkem Limited (ASX|TSX: AKE, “Allkem”) announced that they have obtained all requisite shareholder approvals necessary to complete the merger of equals transaction previously announced on May 10, 2023. The two companies expect to cl

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 19, 2023 LIVENT CORPORAT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 19, 2023 LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorporation or organization

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 13, 2023 LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorporation or organization

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 13, 2023 LIVENT CORPORAT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 13, 2023 LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorporation or organization

1

Filed by Arcadium Lithium plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-6 under the Securities Exchange Act of 1934 Subject Company: Livent Corporation Commission File No.

1

Filed by Livent Corporation pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-6 under the Securities Exchange Act of 1934 Subject Company: Livent Corporation Commission File No.

Filed by Arcadium Lithium plc

Filed by Arcadium Lithium plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-6 under the Securities Exchange Act of 1934 Subject Company: Livent Corporation Commission File No.

Filed by Livent Corporation

Filed by Livent Corporation pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-6 under the Securities Exchange Act of 1934 Subject Company: Livent Corporation Commission File No.

Livent Announces Special Meeting Date to Vote on Pending Merger of Equals with Allkem; Form S-4 Registration Statement Declared Effective

425 1 dp202980425-livent.htm FORM 425 Filed by Livent Corporation pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-6 under the Securities Exchange Act of 1934 Subject Company: Livent Corporation Commission File No. 333-273360 Below is a news release by Livent Corporation. Livent Announces Special Meeting Date to Vote on Pending Merger of Equals with Allke

Livent Announces Special Meeting Date to Vote on Pending Merger of Equals with Allkem; Form S-4 Registration Statement Declared Effective

Filed by Arcadium Lithium plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-6 under the Securities Exchange Act of 1934 Subject Company: Livent Corporation Commission File No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant  ☐ Check the appropriate box:  ☐ Preliminary Proxy Statement  ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy Statement  ☐ Definitive Additional Materials  ☐ Soliciting Material under §240.

CONSENT OF QUALIFIED PERSON

Exhibit 23.7 CONSENT OF QUALIFIED PERSON I, Sean Kosinski, in connection with Livent Corporation’s Current Report on Form 8-K dated November 15, 2023 (the “Form 8-K”), consent to: • the public filing by Livent Corporation (the “Company”) and use of the amended technical report titled “Resource and Reserve Report, Pre-Feasibility Study, Salar del Hombre Muerto, Argentina” (as amended, the “Technica

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 15, 2023 LIVENT CORPORAT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 15, 2023 LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorporation or organization

bec, as amended November 14, 2023 (Exhibit 96.2 to Livent's Current Report on Form 8-K filed on November 15, 2023)

Exhibit 96.2 SEC TECHNICAL REPORT SUMMARY Pre-Feasibility Study ON THE WHABOUCHI MINE NEMASKA, QUEBEC UTM Zone 18N 441000 m E; 5725750 m N Prepared for: Livent Corporation Report Date: September 8, 2023 Effective Date: December 31, 2022 Amended Date: November 14, 2023 Prepared By: BBA Inc. DRA Americas Inc. SGS Geological Services WSP Canada Inc. S-K 1300 Technical Report – Nemaska Whabouchi Mine

Technical Report Summary, Pre-Feasibility Study, Salar del Hombre Muerto, Argentina, as amended November 14, 2023 (Exhibit 96.1 to Livent's Current Report on Form 8-K filed on November 15, 2023)

Exhibit 96.1 RESOURCE AND RESERVE REPORT Pre-Feasibility Study Salar del Hombre Muerto Effective Date: December 31, 2022 Report Date: February 21, 2023 Amended Date: November 14, 2023 Prepared for Prepared by Livent USA Corp. Integral Consulting Inc. 1818 Market Street 1701 Pearl Street Suite 2550 Suite 200 Philadelphia, PA 19103 Boulder, CO 80302 Contents LIST OF FIGURES viii LIST OF TABLES xiii

# # #

Filed by Arcadium Lithium plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Livent Corporation Commission File No.

# # #

Filed by Livent Corporation pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Livent Corporation Commission File No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2023 ☐ Transition Report Pursuant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2023 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number 001-38694 LIVENT CORPORATIO

Second Amendment to the Transaction Agreement, dated as of November 5, 2023, by and between Livent Corporation and Allkem (Exhibit 2.2 to Livent's Quarterly Report on Form 10-Q filed on November 9, 2023)

Exhibit 2.2 1 SECOND AMENDMENT TO TRANSACTION AGREEMENT This SECOND AMENDMENT TO TRANSACTION AGREEMENT (this “Amendment”), dated as of November 5, 2023, is by and between Livent Corporation, a Delaware corporation (“Livent”), and Allkem Limited, an Australian public company limited by shares (“Allkem”). Each of Livent and Allkem are referred to as a “Party,” and collectively, as the “Parties.” WHE

1

Filed by Arcadium Lithium plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Livent Corporation Commission File No.

1

Filed by Livent Corporation pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Livent Corporation Commission File No.

Filed by Arcadium Lithium plc

Filed by Arcadium Lithium plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Livent Corporation Commission File No.

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 31, 2023 LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorporation or organization)

Filed by Livent Corporation

Filed by Livent Corporation pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Livent Corporation Commission File No.

Filed by Livent Corporation

Filed by Livent Corporation pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Livent Corporation Commission File No.

-- Reports Higher Adjusted EBITDA Versus Prior Year -- -- Merger of Equals with Allkem Remains on Track to Close Around Year End -- -- Releases Feasibility Study for Nemaska Lithium Project -- -- Provides Update on the Progress of Capacity Expansions

Exhibit 99.1 Livent Corporation 1818 Market Street, Suite 2550 Philadelphia, PA 19103 USA 215.299.5900 Livent.com News Release Media Contact: Juan Carlos Cruz +1.215.299.6725 [email protected] Investor Contact: Daniel Rosen +1.215.299.6208 [email protected] Livent Releases Third Quarter 2023 Results - Reports Higher Adjusted EBITDA Versus Prior Year - - Merger of Equals with Allkem

Filed by Arcadium Lithium plc

Filed by Arcadium Lithium plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Livent Corporation Commission File No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 24, 2023 LIVENT CORPORATI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 24, 2023 LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorporation) (Commission Fil

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 24, 2023 LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorporation) (Commission Fil

CONVERSION NOTICE TO THE HOLDERS OF LIVENT CORPORATION 4.125% CONVERTIBLE SENIOR NOTES DUE 2025 CUSIP No. 53814L AB4 ISIN No. US53814LAB45 October 19, 2023

Exhibit 99.1 CONVERSION NOTICE TO THE HOLDERS OF LIVENT CORPORATION 4.125% CONVERTIBLE SENIOR NOTES DUE 2025 CUSIP No. 53814L AB4 ISIN No. US53814LAB45 October 19, 2023 WHEREAS, Livent Corporation (the “Company”) entered into that certain Transaction Agreement, dated as of May 10, 2023 (the “Transaction Agreement”), by and among the Company, Allkem Limited, an Australian public company limited by

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 19, 2023 LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorporation) (Commission Fil

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 25, 2023 LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorporation or organizatio

SEC TECHNICAL REPORT SUMMARY Pre-Feasibility Study ON THE WHABOUCHI MINE NEMASKA, QUEBEC UTM Zone 18N 441000 m E; 5725750 m N Prepared for: Livent Corporation Report Date: September 8, 2023 Effective Date: December 31, 2022 Prepared By: BBA Inc. DRA

Exhibit 96.1 SEC TECHNICAL REPORT SUMMARY Pre-Feasibility Study ON THE WHABOUCHI MINE NEMASKA, QUEBEC UTM Zone 18N 441000 m E; 5725750 m N Prepared for: Livent Corporation Report Date: September 8, 2023 Effective Date: December 31, 2022 Prepared By: BBA Inc. DRA Americas Inc. SGS Geological Services WSP Canada Inc. S-K 1300 Technical Report – Nemaska Whabouchi Mine Project – Nemaska, Quebec Page i

Page 1 of 5

August 31, 2023 United States Securities and Exchange Commission Division of Corporation Finance 100 F.

Filed by Allkem Livent plc

Filed by Allkem Livent plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Livent Corporation Commission File No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2023 ☐ Transition Report Pursuant to S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2023 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number 001-38694 LIVENT CORPORATION (Ex

Filed by Livent Corporation

Filed by Livent Corporation pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Livent Corporation Commission File No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 3, 2023 LIVENT CORPORATION

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 3, 2023 LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorporation or organization) (

Filed by Livent Corporation

Filed by Livent Corporation pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Livent Corporation Commission File No.

Filed by Allkem Livent plc

Filed by Allkem Livent plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Livent Corporation Commission File No.

-- Reports Strong Q2 Financial Performance and Reaffirms 2023 Full Year Guidance Range -- -- Publishes 2022 Sustainability Report -- -- Highlights Nemaska Lithium Development Progress, Including Long-Term Supply Agreement with Ford -- -- Proposed Mer

Exhibit 99.1 Livent Corporation 1818 Market Street, Suite 2550 Philadelphia, PA 19103 USA 215.299.5900 Livent.com News Release Media Contact: Juan Carlos Cruz +1.215.299.6725 [email protected] Investor Contact: Daniel Rosen +1.215.299.6208 [email protected] Livent Releases Second Quarter 2023 Results - Reports Strong Q2 Financial Performance and Reaffirms 2023 Full Year Guidance Ra

Filed by Allkem Livent plc

Filed by Allkem Livent plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Livent Corporation Commission File No.

Filed by Livent Corporation

Filed by Livent Corporation pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Livent Corporation Commission File No.

Allkem and Livent Announce Board of Directors for New TopCo

Exhibit 99.1 Allkem and Livent Announce Board of Directors for New TopCo August 2, 2023 Allkem Limited (ASX|TSX: AKE, “Allkem”) and Livent Corporation (NYSE: LTHM, “Livent”) provide an update in relation to the proposed merger of equals between Allkem and Livent previously announced on 10 May 2023 (“Transaction”). Each of Allkem’s and Livent’s Board of Directors have now selected their respective

Allkem and Livent Announce Board of Directors for New TopCo

Exhibit 99.1 Allkem and Livent Announce Board of Directors for New TopCo August 2, 2023 Allkem Limited (ASX|TSX: AKE, “Allkem”) and Livent Corporation (NYSE: LTHM, “Livent”) provide an update in relation to the proposed merger of equals between Allkem and Livent previously announced on 10 May 2023 (“Transaction”). Each of Allkem’s and Livent’s Board of Directors have now selected their respective

Amendment to Transaction Agreement, dated as of August 2, 2023, by and between Livent Corporation, a Delaware corporation, and Allkem Limited, an Australian public company limited by shares.

Exhibit 2.1 EXECUTION VERSION AMENDMENT TO TRANSACTION AGREEMENT This AMENDMENT TO TRANSACTION AGREEMENT (this “Amendment”), dated as of August 2, 2023, is by and between Livent Corporation, a Delaware corporation (“Livent”), and Allkem Limited, an Australian public company limited by shares (“Allkem”). Each of Livent and Allkem are referred to as a “Party,” and collectively, as the “Parties.” WHE

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 2, 2023 LIVENT CORPORATION

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 2, 2023 LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorporation) (Commission File

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 2, 2023 LIVENT CORPORATION

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 2, 2023 LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorporation) (Commission File

Amendment to the Transaction Agreement, dated as of August 2, 2023, by and between Livent Corporation, a Delaware corporation, and Allkem Limited, an Australian public company limited by shares (Exhibit 2.1 to Livent's Current Report on Form 8-K filed on August 2, 2023)

Exhibit 2.1 EXECUTION VERSION AMENDMENT TO TRANSACTION AGREEMENT This AMENDMENT TO TRANSACTION AGREEMENT (this “Amendment”), dated as of August 2, 2023, is by and between Livent Corporation, a Delaware corporation (“Livent”), and Allkem Limited, an Australian public company limited by shares (“Allkem”). Each of Livent and Allkem are referred to as a “Party,” and collectively, as the “Parties.” WHE

Filed by Allkem Livent plc

Filed by Allkem Livent plc pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Livent Corporation Commission File No.

Filed by Lightning-A Limited

425 1 dp195542425-lightning.htm FORM 425 Filed by Lightning-A Limited pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Livent Corporation Commission File No. 001-38694 The below communication was sent by Livent Corporation’s (“Livent”) Chief Executive Officer, Mr. Paul Graves, to the employees

Filed by Livent Corporation

Filed by Livent Corporation pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Livent Corporation Commission File No.

Filed by Lightning-A Limited

Filed by Lightning-A Limited pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Livent Corporation Commission File No.

Filed by Livent Corporation

425 1 dp195365425-livent.htm FORM 425 Filed by Livent Corporation pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Livent Corporation Commission File No. 001-38694 On June 15, 2023, Livent Corporation made available a replay of an interview with Mr. Paul Graves, its Chief Executive Officer. A c

On June 8, Livent Corporation made available a replay of an interview with Mr. Paul Graves, its Chief Executive Officer. A copy of the transcript follows.

Filed by Lightning-A Limited pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Livent Corporation Commission File No.

On June 8, Livent Corporation made available a replay of an interview with Mr. Paul Graves, its Chief Executive Officer. A copy of the transcript follows.

Filed by Livent Corporation pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Livent Corporation Commission File No.

Filed by Livent Corporation

Filed by Livent Corporation pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Livent Corporation Commission File No.

Filed by Livent Corporation

Filed by Livent Corporation pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Livent Corporation Commission File No.

TRANSACTION AGREEMENT by and among ALLKEM LIMITED LIGHTNING-A LIMITED (“New Topco”) – and – LIVENT CORPORATION (“Lion”) dated as of May 10, 2023 TABLE OF CONTENTS

Exhibit 99.1 Allkem and Livent to Create a Leading Global Integrated Lithium Chemicals Producer May 10, 2023 Allkem and Livent announce definitive agreement to combine in an all-stock merger of equals valuing the combined company at US$10.6 billion (A$15.7 billion)1 Key Highlights · Creates a leading global lithium chemicals producer, with pro-forma CY’22 combined revenue of approximately US$1.9 b

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 10, 2023 LIVENT CORPORATION (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 10, 2023 LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorporation) (Commission File Nu

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 10, 2023 LIVENT CORPORATION (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 10, 2023 LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorporation) (Commission File Nu

On May 10, 2023, Paul Graves, the Chief Executive Officer of Livent Corporation, delivered the following letter to certain customers regarding its proposed combination with Allkem Limited.

Filed by Livent Corporation pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Livent Corporation Commission File No.

Livent and Allkem to Create a Leading Global Integrated Lithium Chemicals Producer May 10, 2023

Exhibit 99.2 Livent and Allkem to Create a Leading Global Integrated Lithium Chemicals Producer May 10, 2023 2 Today’s Presenters Martín Pérez de Solay Managing Director & CEO, Allkem Paul Graves President & CEO, Livent Transaction Details Notes: 1. Allkem shareholders to receive one NewCo ASX - listed CDI for each Allkem share held (with the ability to elect to receive NewCo NYSE - listed shares

Transaction Agreement, dated as of May 10, 2023, by and among Livent, Allkem and New Topco (Exhibit 2.1 to Livent's Current Report on Form 8-K filed on May, 10, 2023)

Exhibit 2.1 TRANSACTION AGREEMENT by and among ALLKEM LIMITED (“Anaconda”) LIGHTNING-A LIMITED (“New Topco”) – and – LIVENT CORPORATION (“Lion”) dated as of May 10, 2023 TABLE OF CONTENTS Page ARTICLE I. THE SCHEME 3 Section 1.1. The Scheme 3 Section 1.2. Responsibilities of Anaconda in Respect of the Scheme 3 Section 1.3. Responsibilities of Lion and New Topco in Respect of the Scheme 5 Section 1

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 10, 2023 LIVENT CORPORATION (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 10, 2023 LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorporation) (Commission File Nu

On May 10, 2023, Paul Graves, the Chief Executive Officer of Livent Corporation, delivered the following letter to certain suppliers regarding its proposed combination with Allkem Limited.

Filed by Livent Corporation pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Livent Corporation Commission File No.

TRANSACTION AGREEMENT by and among ALLKEM LIMITED LIGHTNING-A LIMITED (“New Topco”) – and – LIVENT CORPORATION (“Lion”) dated as of May 10, 2023 TABLE OF CONTENTS

Exhibit 99.1 Allkem and Livent to Create a Leading Global Integrated Lithium Chemicals Producer May 10, 2023 Allkem and Livent announce definitive agreement to combine in an all-stock merger of equals valuing the combined company at US$10.6 billion (A$15.7 billion)1 Key Highlights · Creates a leading global lithium chemicals producer, with pro-forma CY’22 combined revenue of approximately US$1.9 b

Page 1 of 13 ©2023, AlphaSense, Inc. All Rights Reserved. AlphaSense is a service mark of AlphaSense, Inc. All other trademarks mentioned belong to their respective owners.

Filed by Livent Corporation pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Livent Corporation Commission File No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 10, 2023 LIVENT CORPORATION (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 10, 2023 LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorporation) (Commission File Nu

Filed by Livent Corporation

Filed by Livent Corporation pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Livent Corporation Commission File No.

Livent and Allkem to Create a Leading Global Integrated Lithium Chemicals Producer May 10, 2023

Exhibit 99.2 Livent and Allkem to Create a Leading Global Integrated Lithium Chemicals Producer May 10, 2023 2 Today’s Presenters Martín Pérez de Solay Managing Director & CEO, Allkem Paul Graves President & CEO, Livent Transaction Details Notes: 1. Allkem shareholders to receive one NewCo ASX - listed CDI for each Allkem share held (with the ability to elect to receive NewCo NYSE - listed shares

###

Filed by Livent Corporation pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Livent Corporation Commission File No.

Livent and Allkem Combination Announcement Frequently Asked Questions (FAQs)

Filed by Livent Corporation pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Livent Corporation Commission File No.

Transaction Agreement, dated as of May 10, 2023, by and among the Company, Allkem and New Topco

Exhibit 2.1 TRANSACTION AGREEMENT by and among ALLKEM LIMITED (“Anaconda”) LIGHTNING-A LIMITED (“New Topco”) – and – LIVENT CORPORATION (“Lion”) dated as of May 10, 2023 TABLE OF CONTENTS Page ARTICLE I. THE SCHEME 3 Section 1.1. The Scheme 3 Section 1.2. Responsibilities of Anaconda in Respect of the Scheme 3 Section 1.3. Responsibilities of Lion and New Topco in Respect of the Scheme 5 Section 1

On May 10, 2023, Paul Graves, the Chief Executive Officer of Livent Corporation, delivered the following letter to certain partners regarding its proposed combination with Allkem Limited.

Filed by Livent Corporation pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Livent Corporation Commission File No.

Filed by Livent Corporation

Filed by Livent Corporation pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Livent Corporation Commission File No.

Livent Corporation Compensation Policy for Non-Employee Directors, as of

amendedandrestatednon-em LIVENT CORPORATION COMPENSATION POLICY FOR NON-EMPLOYEE DIRECTORS (Amended and Restated Effective May 1, 2023) PART I - GENERAL PROVISIONS 1.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2023 ☐ Transition Report Pursuant to

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2023 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number 001-38694 LIVENT CORPORATION (E

-- Reports Record Financial Performance in the First Quarter -- -- Nemaska Lithium Achieves Significant Milestones -- -- Raises 2023 Full Year Revenue and Adjusted EBITDA Guidance --

Exhibit 99.1 Livent Corporation 1818 Market Street, Suite 2550 Philadelphia, PA 19103 USA 215.299.5900 Livent.com News Release Media Contact: Juan Carlos Cruz +1.215.299.6725 [email protected] Investor Contact: Daniel Rosen +1.215.299.6208 [email protected] Livent Releases First Quarter 2023 Results - Reports Record Financial Performance in the First Quarter - - Nemaska Lithium Ach

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 2, 2023 LIVENT CORPORATION (E

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 2, 2023 LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorporation or organization) (Com

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 25, 2023 LIVENT CORPORATIO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 25, 2023 LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorporation or organization)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for use of the Commission only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy

DEAR STOCKHOLDER

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for use of the Commission only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy

DEAR STOCKHOLDER

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for use of the Commission only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2022 ☐ Transition Report Pursuant to Secti

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2022 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number 001-38694 LIVENT C

Subsidiaries of the Registrant

Exhibit 21 LIVENT CORPORATION SIGNIFICANT SUBSIDIARIES OF THE REGISTRANT The following is a list of the Company’s consolidating subsidiaries, as of December 31, 2022, except for certain subsidiaries of the Registrant which do not, in the aggregate, constitute a significant subsidiary as that term is defined in Rule 12b-2 under the Securities Exchange Act of 1934.

Pre-Feasibility Study, Salar del Hombre Muerto, Argentina, prepared by Integral Consulting Inc., dated February 21, 2023

mdafinalresourceandreser Normal Normal RESOURCE AND RESERVE REPORT Pre-Feasibility Study Salar del Hombre Muerto February 21, 2023 Prepared for Prepared by Integral Consulting Inc.

-- Strong Fourth Quarter Caps Record Financial Performance in 2022 -- -- Capacity Expansions Expected to Drive 20% Higher Sales Volumes in 2023 -- -- 50% Adjusted EBITDA(1) Growth at Midpoint of 2023 Guidance --

Exhibit 99.1 Livent Corporation 1818 Market Street, Suite 2550 Philadelphia, PA 19103 USA 215.299.5900 Livent.com News Release For Release: Immediate Media Contact: Juan Carlos Cruz +1.215.299.6725 [email protected] Investor Contact: Daniel Rosen +1.215.299.6208 [email protected] Livent Releases Fourth Quarter and Full Year 2022 Results - Strong Fourth Quarter Caps Record Financial

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 14, 2023 LIVENT CORPORAT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 14, 2023 LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorporation or organization

LTHM / Livent Corp / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SC 13G/A 1 tv01322-liventcorp.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 4)* Name of issuer: Livent Corp. Title of Class of Securities: Common Stock CUSIP Number: 53814L108 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designate the rule p

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2022 ☐ Transition Report Pursuant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2022 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number 001-38694 LIVENT CORPORATIO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 1, 2022 LIVENT CORPORATI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 1, 2022 LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorporation or organization)

-- Record Financial Performance Achieved in Third Quarter -- -- Capacity Expansions Remain on Track -- -- Increasing Midpoint of 2022 Full Year Adjusted EBITDA Guidance --

Exhibit 99.1 Livent Corporation 1818 Market Street, Suite 2550 Philadelphia, PA 19103 USA 215.299.5900 Livent.com News Release Media Contact: Juan Carlos Cruz +1.215.299.6725 [email protected] Investor Contact: Daniel Rosen +1.215.299.6208 [email protected] Livent Releases Third Quarter 2022 Results - Record Financial Performance Achieved in Third Quarter - - Capacity Expansions Re

Amended and Restated Credit Agreement, dated as of September 1, 2022 (Exhibit 10.1 to Current Report on Form 8-K filed on September 2, 2022)

Execution Version WEIL:\98721861\10\35899.0596 ??????????????????????????????????????? $500,000,000 AMENDED AND RESTATED CREDIT AGREEMENT Dated as of September 1, 2022 among LIVENT CORPORATION and LIVENT USA CORP. as Borrowers THE GUARANTORS PARTY HERETO FROM TIME TO TIME as Guarantors THE LENDERS AND ISSUING BANKS PARTY HERETO and CITIBANK, N.A., as Administrative Agent, * * * CITIBANK, N.A., BOF

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 2, 2022 LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorporation or organization

Executive Severance Guidelines, as amended August 1, 2022

Livent Corporation Executive Severance Guidelines for Designated Executives Background The intent of these severance guidelines (?Guidelines?) is to provide designated executives of Livent Corporation (the ?Company?) with reasonable transition benefits in the event of a termination of employment without cause (other than in the context of a change in control, or as a result of death, disability or retirement).

Amendment to the Merger Agreement, dated May 25, 2022

AMENDMENT TO TRANSACTION AGREEMENT AND PLAN OF MERGER This AMENDMENT TO TRANSACTION AGREEMENT AND PLAN OF MERGER (the ?Amendment?) made as of the 25th day of May, 2022 by and among LIVENT CORPORATION, a Delaware corporation (?Livent?), REACH MERGECO LIMITED, a non- cellular company incorporated in Guernsey with registration number 70586 (?Merger Sub?), PALLINGHURST LITHIUM LIMITED, a non-cellular company incorporated in Guernsey with registration number 68222 (?PLL?), PALLINGHURST GP LIMITED, a company incorporated in the Cayman Islands (?PGPL?), and AMOS CAPITAL LIMITED (formerly known as The Pallinghurst Group General Partner Limited), a company incorporated in the Cayman Islands (?ACL?).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2022 ☐ Transition Report Pursuant to S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2022 or ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number 001-38694 LIVENT CORPORATION (Ex

Livent Certificate of Incorporation as amended June 2, 2022

AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF LIVENT CORPORATION (as amended through June 2, 2022) Livent Corporation (the ?Corporation?), a corporation organized and existing under the General Corporation Law of the State of Delaware as the same exists or may hereafter be amended (the ?Delaware Act?), was originally incorporated under the name FMC Lithium USA Holding Corp.

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 2, 2022 LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorporation or organization) (

-- Record Financial Performance Achieved in Second Quarter -- -- Entered into Long-Term Supply Agreement with General Motors -- -- Raises 2022 Full Year Revenue and Adjusted EBITDA Guidance --

Exhibit 99.1 Livent Corporation 1818 Market Street, Suite 2550 Philadelphia, PA 19103 USA 215.299.5900 Livent.com News Release Media Contact: Juan Carlos Cruz +1.215.299.6725 [email protected] Investor Contact: Daniel Rosen +1.215.299.6208 [email protected] LIVENT RELEASES SECOND QUARTER 2022 RESULTS - Record Financial Performance Achieved in Second Quarter - - Entered into Long-Te

Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 10, 2022 (June 6, 2022) LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other Jurisdiction of Incorporation) (Co

Form of Employee PRSU Award Agreement under the Livent Corporation Incentive Compensation and Stock Plan (Exhibit 10.1 to the Livent's Quarterly Report on Form 10-Q filed on May 5, 2022)

124126485v15 PERFORMANCE-BASED RESTRICTED STOCK UNIT AWARD AGREEMENT UNDER THE LIVENT CORPORATION INCENTIVE COMPENSATION AND STOCK PLAN This PERFORMANCE-BASED RESTRICTED STOCK UNIT AWARD AGREEMENT (this ?Agreement?) is made by and between Livent Corporation (the ?Company?) and [Participant Name] (the ?Participant?).

Transaction Agreement and Plan of Merger, dated as of May 2, 2022, among Livent Corporation, Reach Mergeco Limited, Pallinghurst Lithium Limited, Pallinghurst GP Limited and The Pallinghurst Group General Partner Limited*

TRANSACTION AGREEMENT AND PLAN OF MERGER dated as of May 2, 2022 among LIVENT CORPORATION, REACH MERGECO LIMITED, PALLINGHURST LITHIUM LIMITED, PALLINGHURST GP LIMITED and THE PALLINGHURST GROUP GENERAL PARTNER LIMITED TABLE OF CONTENTS Page Article 1 Definitions 2 Section 1.

# # #

Media Contact: Juan Carlos Cruz +1.215.299.6725 [email protected] Investor Contact: Daniel Rosen +1.215.299.6208 [email protected] LIVENT ANNOUNCES AGREEMENT TO DOUBLE ITS OWNERSHIP STAKE IN NEMASKA LITHIUM TO 50 PERCENT PHILADELPHIA, May 2, 2022 ? Livent Corporation (NYSE: LTHM) today announced that it has agreed to double its ownership interest to 50% in Nemaska Lithium Inc. (?Ne

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 5, 2022 (May 2, 2022) LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other Jurisdiction of Incorporation) (Commi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2022 ☐ Transition Report Pursuant to

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2022 or ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number 001-38694 LIVENT CORPORATION (E

-- Strong First Quarter Performance with Adjusted EBITDA Almost Double Q4 2021 -- -- Significantly Raises Full Year Guidance with 2022 Adjusted EBITDA Almost 5x 2021 -- -- Announces Multiple Additional Carbonate and Hydroxide Capacity Expansions -- -

Exhibit 99.1 Livent Corporation 1818 Market Street, Suite 2550 Philadelphia, PA 19103 USA 215.299.5900 Livent.com News Release Media Contact: Juan Carlos Cruz +1.215.299.6725 [email protected] Investor Contact: Daniel Rosen +1.215.299.6208 [email protected] LIVENT RELEASES FIRST QUARTER 2022 RESULTS - Strong First Quarter Performance with Adjusted EBITDA Almost Double Q4 2021 - - S

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 3, 2022 LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorporation or organization) (Com

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 26, 2022 LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorporation or organization)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14A-6(e)(2)) Definitive Prox

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No.

I. GENERAL INFORMATION II. THE PROPOSALS TO BE VOTED ON III. BOARD OF DIRECTORS IV. INFORMATION ABOUT THE BOARD OF DIRECTORS AND CORPORATE GOVERNANCE V. SECURITY OWNERSHIP OF LIVENT CORPORATION VI. EXECUTIVE COMPENSATION VII. OTHER MATTERS APPENDIX A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No.

I. GENERAL INFORMATION II. THE PROPOSALS TO BE VOTED ON III. BOARD OF DIRECTORS IV. INFORMATION ABOUT THE BOARD OF DIRECTORS AND CORPORATE GOVERNANCE V. SECURITY OWNERSHIP OF LIVENT CORPORATION VI. EXECUTIVE COMPENSATION VII. OTHER MATTERS APPENDIX A

PRE 14A 1 llthm2022pre14a.htm LIVENT CORP. - PRE 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for use of the Commission onl

Form of Employee Option Award Agreement under the Livent Corporation Incentive Compensation and Stock Plan

#113565746 v2 NONQUALIFIED STOCK OPTION AWARD AGREEMENT UNDER THE LIVENT CORPORATION INCENTIVE COMPENSATION AND STOCK PLAN This NONQUALIFIED STOCK OPTION AWARD AGREEMENT (this ?Agreement?) is made by and between Livent Corporation (the ?Company?) and [Participant Name] (the ?Participant?).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2021 ☐ Transition Report Pursuant to Secti

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2021 or ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number 001-38694 LIVENT C

Fourth Amendment to the Credit Agreement, dated December 28, 2021, by and among Livent Corporation, Livent USA Corp., the guarantor subsidiaries described therein, Citibank, N.A., as administrative agent, and the lenders and issuing banks listed therein

EXECUTION VERSION WEIL:\98229966\5\35899.0596 FOURTH AMENDMENT TO CREDIT AGREEMENT FOURTH AMENDMENT TO CREDIT AGREEMENT (this ?Amendment?), dated as of December 28, 2021, by and among LIVENT CORPORATION, a Delaware corporation (?Livent?), LIVENT USA CORP. (f/k/a FMC LITHIUM USA CORP., a Delaware corporation (together with Livent, collectively, the ?Borrowers? and, each, a ?Borrower?), the Guaranto

Subsidiaries of the Registrant

Exhibit 21 LIVENT CORPORATION SIGNIFICANT SUBSIDIARIES OF THE REGISTRANT The following is a list of the Company?s consolidating subsidiaries, as of December 31, 2021, except for certain subsidiaries of the Registrant which do not, in the aggregate, constitute a significant subsidiary as that term is defined in Rule 12b-2 under the Securities Exchange Act of 1934.

Third Amendment to the Credit Agreement, dated November 5, 2021, by and among Livent Corporation, Livent USA Corp., the guarantor subsidiaries described therein, Citibank, N.A., as administrative agent, and the lenders and issuing banks listed therein

EXECUTION VERSION WEIL:\98229966\5\35899.0596 THIRD AMENDMENT TO CREDIT AGREEMENT THIRD AMENDMENT TO CREDIT AGREEMENT (this ?Amendment?), dated as of November 5, 2021, by and among LIVENT CORPORATION, a Delaware corporation (?Livent?), FMC LITHIUM USA CORP., a Delaware corporation (together with Livent, collectively, the ?Borrowers? and, each, a ?Borrower?), the Guarantors (as defined below), the

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 17, 2022 LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorporation or organization

-- Strong Quarter with Full Year 2021 Results at the Top of Guidance -- -- 2022 Adjusted EBITDA Guidance Almost Three-Times 2021 at the High End of Range -- -- Announces New 20,000 MT Lithium Carbonate Expansion in Argentina --

EX-99.1 2 liventex99112312021.htm EX-99.1 Exhibit 99.1 Livent Corporation 1818 Market Street, Suite 2550 Philadelphia, PA 19103 USA 215.299.5900 Livent.com News Release For Release: Immediate Media Contact: Juan Carlos Cruz +1.215.299.6725 [email protected] Investor Contact: Daniel Rosen +1.215.299.6208 [email protected] LIVENT RELEASES FOURTH QUARTER 2021 RESULTS - Strong Quarter

LTHM / Livent Corp / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 3)* Name of issuer: Livent Corp. Title of Class of Securities: Common Stock CUSIP Number: 53814L108 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ??Rule 1

-- Strong Market Conditions Drove Higher Pricing and Demand -- -- Logistics Disruptions Continue to Impact Lithium Supply Chains -- -- Carbonate and Hydroxide Expansions Remain on Track -- -- Increasing Full Year Guidance --

Exhibit 99.1 Livent Corporation 1818 Market Street, Suite 2550 Philadelphia, PA 19103 USA 215.299.5900 Livent.com News Release Media Contact: Juan Carlos Cruz +1.215.299.6725 [email protected] Investor Contact: Daniel Rosen +1.215.299.6208 [email protected] LIVENT RELEASES THIRD QUARTER 2021 RESULTS - Strong Market Conditions Drove Higher Pricing and Demand - - Logistics Disruption

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2021 ☐ Transition Report Pursuant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2021 or ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number 001-38694 LIVENT CORPORATIO

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 4, 2021 LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorporation or organization)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2021 ☐ Transition Report Pursuant to S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2021 or ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number 001-38694 LIVENT CORPORATION (Ex

-- Higher Volumes and Pricing Drove Strong Sequential Improvement -- -- Completed $262 Million Equity Issuance to Fund Capacity Expansion -- -- Released 2020 Sustainability Report -- -- Raising Full Year 2021 Guidance --

Exhibit 99.1 Livent Corporation 1818 Market Street, Suite 2550 Philadelphia, PA 19103 USA 215.299.5900 Livent.com News Release Media Contact: Juan Carlos Cruz +1.215.299.6170 [email protected] Investor Contact: Daniel Rosen +1.215.299.6208 [email protected] LIVENT RELEASES SECOND QUARTER 2021 RESULTS - Higher Volumes and Pricing Drove Strong Sequential Improvement - - Completed $26

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 5, 2021 LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorporation or organization) (

Title of Each Class of Securities to be Registered

TABLE OF CONTENTS Filed Pursuant to Rule 424(b)(5) Registration No. 333-256939 Title of Each Class of Securities to be Registered ? ? Amount to be Registered(1) ? ? Proposed Maximum Offering Price per Share ? ? Proposed Maximum Aggregate Offering Price ? ? Amount of Registration Fee(2) Common stock, par value $0.001 per share ? ? 14,950,000 ? ? $17.50 ? ? $261,625,000 ? ? $28,543.29 (1) Includes 1

LIVENT CORPORATION (A Delaware corporation) 13,000,000 Shares of Common Stock UNDERWRITING AGREEMENT

Exhibit 1.1 Execution Version LIVENT CORPORATION (A Delaware corporation) 13,000,000 Shares of Common Stock UNDERWRITING AGREEMENT Dated: June 10, 2021 LIVENT CORPORATION (a Delaware corporation) 13,000,000 Shares of Common Stock UNDERWRITING AGREEMENT June 10, 2021 Goldman Sachs & Co. LLC J.P. Morgan Securities LLC as Representatives of the several Underwriters c/o Goldman Sachs & Co. LLC 200 Wes

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 10, 2021 LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorporation or organization) (C

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 10, 2021 LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorporation or organization) (C

SUBJECT TO COMPLETION, DATED JUNE 9, 2021

TABLE OF CONTENTS The information in this preliminary prospectus supplement and the accompanying prospectus is not complete and may be changed.

LIVENT CORPORATION Dated as of ___________ ___, 20__ Livent Corporation Certain Sections of this Indenture relating to Sections 3.10 through 3.18, inclusive, of the Trust Indenture Act of 1939:

Exhibit 4.3 LIVENT CORPORATION and [], Trustee INDENTURE Dated as of , 20 Livent Corporation Certain Sections of this Indenture relating to Sections 3.10 through 3.18, inclusive, of the Trust Indenture Act of 1939: Trust Indenture Act Section Indenture Section ? 310 (a)(1) 6.09 (a)(2) 6.09 (a)(3) Not Applicable (a)(4) Not Applicable (a)(5) 6.09 (b) 6.07 (c) Not Applicable ? 311 (a) 6.10 (b) 6.10 (

As filed with the Securities and Exchange Commission on June 9, 2021

TABLE OF CONTENTS As filed with the Securities and Exchange Commission on June 9, 2021 Registration No.

Other Events

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 9, 2021 LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorporation or

Quarterly Report - 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2021 or ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number 001-38694 LIVENT CORPORATION (E

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 29, 2021 LIVENT CORP. (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorporation or organization) (Commi

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 3, 2021 LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorporation or organization) (Com

-- Higher Volumes and Lower Costs Drove Sequential Improvement -- -- Resumes Capacity Expansion in Argentina and the U.S. -- -- Expects 2021 Performance at Higher End of Guidance Ranges --

Exhibit 99.1 Livent Corporation 2929 Walnut Street Philadelphia, PA 19104 USA 215.299.5900 Livent.com News Release Media Contact: Juan Carlos Cruz +1.215.299.6170 [email protected] Investor Contact: Daniel Rosen +1.215.299.6208 [email protected] LIVENT RELEASES FIRST QUARTER 2021 RESULTS - Higher Volumes and Lower Costs Drove Sequential Improvement - - Resumes Capacity Expansion in

- LIVENT CORP. - DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for use of the Commission only (as permitted by Rule 14a-6(e)(2)) Definitive Prox

- LIVENT CORP. - DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for use of the Commission only (as permitted by Rule 14a-6(e)(2)) Definitive Prox

- LIVENT CORP. - PRE 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for use of the Commission only (as permitted by Rule 14a-6(e)(2)) Definitive Prox

Form of Employee RSU Award Agreement under the Livent Corporation Incentive Compensation and Stock Plan

#113565863 v1 RESTRICTED STOCK UNIT AWARD AGREEMENT UNDER THE LIVENT CORPORATION INCENTIVE COMPENSATION AND STOCK PLAN This RESTRICTED STOCK UNIT AWARD AGREEMENT (this ?Agreement?) is made by and between Livent Corporation (the ?Company?) and [Participant Name] (the ?Participant?).

Livent Corporation Executive Severance Plan, dated as of February 22, 2021, with Form of Agreement.

#113189964 v2 LIVENT CORPORATION EXECUTIVE SEVERANCE PLAN (as amended through February 22, 2021) 1.

Description of Common Stock

Exhibit 4.2 DESCRIPTION OF COMMON STOCK The following description of our Common Stock is a summary and does not purport to be complete. It is subject to and qualified in its entirety by reference to our Amended and Restated Certificate of Incorporation (the ?Certificate of Incorporation?) and our Amended and Restated Bylaws (the ?Bylaws?), each of which are incorporated by reference as an exhibit

Subsidiaries of the Registrant

Exhibit 21 LIVENT CORPORATION SIGNIFICANT SUBSIDIARIES OF THE REGISTRANT The following is a list of the Company?s consolidating subsidiaries, as of December 31, 2020, except for certain subsidiaries of the Registrant which do not, in the aggregate, constitute a significant subsidiary as that term is defined in Rule 12b-2 under the Securities Exchange Act of 1934.

Annual Report - 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2020 or ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number 001-38694 LIVENT C

Executive Severance Agreement, dated as of February 24, 2021, by and between Livent Corporation and Sara Ponessa

EXECUTIVE SEVERANCE AGREEMENT This EXECUTIVE SEVERANCE AGREEMENT is made and entered into as of February 24, 2021 (the ?Effective Date?), by and between Livent Corporation, a Delaware corporation (hereinafter referred to as the ?Company?) and Sara Ponessa (hereinafter referred to as the ?Executive?) (this ?Agreement?).

First Amendment to Trademark License Agreement, dated as of May 11, 2020, by and among FMC Corporation and Livent Corporation

FIRST AMENDMENT TO TRADEMARK LICENSE AGREEMENT FIRST AMENDMENT TO TRADEMARK LICENSE AGREEMENT (this Amendment ) dated as of May 11, 2020 by and among FMC Corporation, a Delaware corporation ( FMC ), and Livent Corporation, a Delaware corporation ( Livent ).

Executive Severance Agreement, dated as of February 23, 2021, by and between Livent Corporation and Paul Graves. Pursuant to Instruction 2 to Item 601 of Regulation S-K, Executive Severance Agreements that are substantially identical in all material respects, except as to the parties thereto, the Executive Severance Agreement between Livent Corporation and Gilberto Antoniazzi was not filed.

EXECUTIVE SEVERANCE AGREEMENT This EXECUTIVE SEVERANCE AGREEMENT is made and entered into as of February 23, 2021 (the ?Effective Date?), by and between Livent Corporation, a Delaware corporation (hereinafter referred to as the ?Company?) and Paul W.

Form of Employee Option Award Agreement under the Livent Corporation Incentive Compensation and Stock Plan

#113565746 v1 NONQUALIFIED STOCK OPTION AWARD AGREEMENT UNDER THE LIVENT CORPORATION INCENTIVE COMPENSATION AND STOCK PLAN This NONQUALIFIED STOCK OPTION AWARD AGREEMENT (this ?Agreement?) is made by and between Livent Corporation (the ?Company?) and [Participant Name] (the ?Participant?).

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 18, 2021 LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorporation or organization

-- Increased Volumes, Higher Realized Pricing and Lower Costs Drove Sequential Improvement -- -- Announces Multi-Year Supply Agreement with BMW Group -- -- Expands on New Sustainability Goals -- -- Provides Full Year 2021 Outlook --

Exhibit 99.1 Livent Corporation 2929 Walnut Street Philadelphia, PA 19104 USA 215.299.5900 Livent.com News Release For Release: Immediate Media Contact: Juan Carlos Cruz +1.215.299.6170 [email protected] Investor Contact: Daniel Rosen +1.215.299.6208 [email protected] LIVENT RELEASES FOURTH QUARTER AND FULL YEAR 2020 RESULTS - Increased Volumes, Higher Realized Pricing and Lower Co

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 2)*

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 2)* Name of issuer: Livent Corp. Title of Class of Securities: Common Stock CUSIP Number: 53814L108 Date of Event Which Requires Filing of this Statement: December 31, 2020 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 1

SCHEDULE 13G

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* Livent Corp. (Name of Issuer) Common Stock (Title of Class of Securities) 53814L108 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule

- S-8

As filed with the Securities and Exchange Commission on January 8, 2021 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Livent Corporation (Exact name of registrant as specified in its charter) 2929 Walnut Street Philadelphia, Pennsylvania, 19104 Delaware 215-299-5900 82-4699376 (State or other jurisdiction of incorporation or organization) (Address, including zip code, of Principal Executive Offices) (I.

Results of Operations and Financial Condition - 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 5, 2020 LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorporation or organization)

-- Announces Agreement to Invest in New Nemaska Lithium in Canada -- -- Extends and Expands Hydroxide Supply Agreement with Tesla -- -- Makes Commitment to Overall Carbon Neutrality by 2040 --

Exhibit 99.1 Livent Corporation 2929 Walnut Street Philadelphia, PA 19104 USA 215.299.5900 Livent.com For Release: Immediate Media Contact: Juan Carlos Cruz +1.215.299.6170 [email protected] Investor Contact: Daniel Rosen +1.215.299.6208 [email protected] LIVENT RELEASES THIRD QUARTER 2020 RESULTS - Announces Agreement to Invest in New Nemaska Lithium in Canada - - Extends and Expa

Quarterly Report - 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2020 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number 001-38694 LIVENT CORPORATIO

-- Weak Q2 Demand Driven by COVID-19 Impact and Auto Supply Chain Disruption -- -- Green Convertible Issuance Significantly Enhances Liquidity Position -- -- Longer Term Electric Vehicle Outlook Remains Strong --

Exhibit 99.1 Livent Corporation 2929 Walnut Street Philadelphia, PA 19104 USA 215.299.5900 Livent.com For Release: Immediate Media Contact: Juan Carlos Cruz +1.215.299.6170 [email protected] Investor Contact: Daniel Rosen +1.215.299.6208 [email protected] LIVENT RELEASES SECOND QUARTER 2020 RESULTS - Weak Q2 Demand Driven by COVID-19 Impact and Auto Supply Chain Disruption - - Gree

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 6, 2020 LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorporation or organization) (

Quarterly Report - 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2020 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number 001-38694 LIVENT CORPORATION (Ex

Second Amendment to the Credit Agreement, dated August 3, 2020, by and among Livent Corporation, Livent USA Corp., the guarantor subsidiaries described therein, Citibank, N.A., as administrative agent, and the lenders and issuing banks listed therein (Exhibit 10.2 to the Registrants Quarterly Report on Form 10-Q for the three months ended June 30, 2020)

EXECUTION VERSION SECOND AMENDMENT TO CREDIT AGREEMENT SECOND AMENDMENT TO CREDIT AGREEMENT (this “Amendment”), dated as of August 3, 2020, by and among LIVENT CORPORATION, a Delaware corporation (“Livent”), FMC LITHIUM USA CORP.

Form of 4.125% Convertible Senior Notes due 2025 (Exhibit 4.2 to Current Report on Form 8-K filed on June 25, 2020)

LIVENT CORPORATION 8-K Exhibit 4.2 EXHIBIT A [FORM OF FACE OF NOTE] [INCLUDE FOLLOWING LEGEND IF A GLOBAL NOTE] [UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE, OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 25, 2020 LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorporation or organization) (C

Indenture, dated as of June 25, 2020, between Livent Corporation and U.S. Bank National Association. (Exhibit 4.1 to Current Report on Form 8-K filed on June 25, 2020)

LIVENT CORPORATION 8-K Exhibit 4.1 EXECUTION VERSION LIVENT CORPORATION AND U.S. Bank National Association, as Trustee INDENTURE Dated as of June 25, 2020 4.125% Convertible Senior Notes due 2025 TABLE OF CONTENTS Page ARTICLE 1 Definitions Section 1.01. Definitions 1 Section 1.02. References to Interest 13 ARTICLE 2 Issue, Description, Execution, Registration and Exchange of Notes Section 2.01. D

# # #

Exhibit 99.1 News Release Livent Corporation 2929 Walnut Street Philadelphia, PA 19104 USA 215.299.5900 livent.com Media contact: Juan Carlos Cruz +1.215.299.6170 [email protected] Investor contact: Daniel Rosen +1.215.299.6208 [email protected] LIVENT ANNOUNCES PROPOSED PRIVATE OFFERING OF $225 MILLION OF CONVERTIBLE SENIOR NOTES DUE 2025 WITH NET PROCEEDS DESIGNED TO ALIGN WITH T

--

Exhibit 99.2 News Release Livent Corporation 2929 Walnut Street Philadelphia, PA 19104 USA 215.299.5900 livent.com Media contact: Juan Carlos Cruz +1.215.299.6170 [email protected] Investor contact: Daniel Rosen +1.215.299.6208 [email protected] LIVENT Announces PRICING OF Private Offering of $225 Million of Convertible Senior Notes DUE 2025 WITH NET PROCEEDS DESIGNED TO ALIGN WITH

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 22, 2020 LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorporation or organization) (C

-- All Production Facilities Fully Operational -- -- Enhanced Liquidity with Covenant Relief and Significantly Reduced 2020 Capex --

Exhibit 99.1 Livent Corporation 2929 Walnut Street Philadelphia, PA 19104 USA 215.299.6000 Livent.com For Release: Immediate Media Contact: Juan Carlos Cruz +1.215.299.6170 [email protected] Investor Contact: Daniel Rosen +1.215.299.6208 [email protected] LIVENT RELEASES FIRST QUARTER 2020 RESULTS - All Production Facilities Fully Operational - - Enhanced Liquidity with Covenant Re

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 11, 2020 LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorporation or organization) (Co

First Amendment to the Credit Agreement, dated May 6, 2020, by and among Livent Corporation, Livent USA Corp., the guarantor subsidiaries described therein, Citibank, N.A., as administrative agent, and the lenders and issuing banks listed therein (Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q for the three months ended March 31, 2020)

liventfirstamendmenttocr EXECUTION VERSION FIRST AMENDMENT TO CREDIT AGREEMENT FIRST AMENDMENT TO CREDIT AGREEMENT (this “Amendment”), dated as of May 6, 2020, by and among LIVENT CORPORATION, a Delaware corporation (“Livent”), FMC LITHIUM USA CORP.

Quarterly Report - 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2020 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number 001-38694 LIVENT CORPORATION (E

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 29, 2020 LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorporation or organization)

Livent Corporation 2929 Walnut Street Philadelphia, PA 19104 USA 215.299.6000 Livent.com News Release Media Contact: Juan Carlos Cruz +1.215.299.6170 [email protected] Investor Contact: Daniel Rosen +1.215.299.6208 [email protected]

Exhibit 99.1 Livent Corporation 2929 Walnut Street Philadelphia, PA 19104 USA 215.299.6000 Livent.com News Release Media Contact: Juan Carlos Cruz +1.215.299.6170 [email protected] Investor Contact: Daniel Rosen +1.215.299.6208 [email protected] Livent Resumes Operations In Argentina PHILADELPHIA, April 6, 2020 /PRNewswire/ - Livent Corporation (NYSE: LTHM) today announced that it

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 6, 2020 LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorporation or organization) (C

Livent Corporation 2929 Walnut Street Philadelphia, PA 19104 USA 215.299.6000 Livent.com News Release Media Contact: Juan Carlos Cruz +1.215.299.6170 [email protected] Investor Contact: Daniel Rosen +1.215.299.6208 [email protected]

Exhibit 99.1 Livent Corporation 2929 Walnut Street Philadelphia, PA 19104 USA 215.299.6000 Livent.com News Release Media Contact: Juan Carlos Cruz +1.215.299.6170 [email protected] Investor Contact: Daniel Rosen +1.215.299.6208 [email protected] LIVENT PROVIDES UPDATE ON STATUS OF ITS ARGENTINA OPERATIONS FOLLOWING GOVERNMENT DECREE PHILADELPHIA, March 23, 2020 - Livent Corporation

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 23, 2020 LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorporation or organization) (

LTHM / Livent Corp. DEF 14A - - LIVENT CORP. - DEF 14A

LIVENT CORPORATION - DEF14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

LTHM / Livent Corp. DEFA14A - - LIVENT CORP. - DEFA14A

LIVENT CORPORATION - DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

LTHM / Livent Corp. PRE 14A - - LIVENT CORP. - PRE 14A

LIVENT CORPORATION - PRE14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

Annual Report - 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2019 or ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number 001-38694 LIVENT C

Preferability Letter

February 28, 2020 Livent Corporation 2929 Walnut Street Philadelphia, Pennsylvania 19104 Ladies and Gentlemen: We have audited the consolidated balance sheets of Livent Corporation (the Company) as of December 31, 2019 and 2018, and the related consolidated and combined statements of operations, comprehensive income, equity, and cash flows for each of the years in the three-year period ended December 31, 2019, and the related notes (collectively, the consolidated and combined financial statements), and have reported thereon under date of February 28, 2020.

Executive Severance Agreement, dated as of October 10, 2018, by and between Livent Corporation and Paul Graves. Pursuant to Instruction 2 to Item 601 of Regulation S-K, Executive Severance Agreements that are substantially identical in all material respects, except as to the parties thereto, between Livent Corporation and Gilberto Antoniazzi was not filed.

pgravesformofexecutivese FORM OF EXECUTIVE SEVERANCE AGREEMENT This EXECUTIVE SEVERANCE AGREEMENT is made and entered into as of October 10, 2018 (the "Effective Date"), by and between Livent Corporation, a Delaware corporation (hereinafter referred to as the "Company") and Paul Graves (hereinafter referred to as the "Executive") (this "Agreement").

Description of Common Stock

Exhibit 4.2 DESCRIPTION OF COMMON STOCK The following description of our Common Stock is a summary and does not purport to be complete. It is subject to and qualified in its entirety by reference to our Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”) and our Amended and Restated Bylaws (the “Bylaws”), each of which are incorporated by reference as an exhibit

Subsidiaries of the Registrant

Exhibit 21 LIVENT CORPORATION SIGNIFICANT SUBSIDIARIES OF THE REGISTRANT The following is a list of the Company’s consolidating subsidiaries, as of December 31, 2019, except for certain subsidiaries of the Registrant which do not, in the aggregate, constitute a significant subsidiary as that term is defined in Rule 12b-2 under the Securities Exchange Act of 1934.

Executive Severance Agreement, dated as of October 10, 2018, by and between Livent Corporation and Sara Ponessa.

sponessaformofexecsevagr FORM OF EXECUTIVE SEVERANCE AGREEMENT This EXECUTIVE SEVERANCE AGREEMENT is made and entered into as of October 10, 2018 (the "Effective Date"), by and between Livent Corporation, a Delaware corporation (hereinafter referred to as the "Company") and Sara Ponessa (hereinafter referred to as the "Executive") (this "Agreement").

-- Provides Full Year 2020 Financial Guidance -- -- Reaffirms and Details 2020 Volume Growth -- -- Slows Pace of Near-Term Capacity Expansion --

Exhibit 99.1 Livent Corporation 2929 Walnut Street Philadelphia, PA 19104 USA 215.299.6000 Livent.com News Release For Release: Immediate Media Contact: Juan Carlos Cruz +1.215.299.6170 [email protected] Investor Contact: Daniel Rosen +1.215.299.6208 [email protected] LIVENT RELEASES FOURTH QUARTER AND FULL YEAR 2019 RESULTS - Provides Full Year 2020 Financial Guidance - - Reaffirm

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 20, 2020 LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorporation or organization

LTHM / Livent Corp. / GLENVIEW CAPITAL MANAGEMENT, LLC Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* LIVENT CORPORATION (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 53814L108 (CUSIP Number) December 31, 2019 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule

LTHM / Livent Corp. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 1)* Name of issuer: Livent Corp Title of Class of Securities: Common Stock CUSIP Number: 53814L108 Date of Event Which Requires Filing of this Statement: December 31, 2019 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 13

Livent Announces Addition of Two New Board Members, Dr. Christina Lampe-Önnerud and Pablo Marcet

Exhibit 99.1 Livent Announces Addition of Two New Board Members, Dr. Christina Lampe-Önnerud and Pablo Marcet PHILADELPHIA, Feb. 3, 2020 /PRNewswire/ - Livent Corporation (NYSE: LTHM) announced today the appointment of Dr. Christina Lampe-Önnerud and Pablo Marcet as new members of its Board of Directors. "We are delighted to welcome Christina and Pablo to the Livent Board," said Pierre Brondeau, c

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 3, 2020 LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorporation or organization)

LTHM / Livent Corp. / Wellington Management Group LLP - SEC SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Livent Corp (Name of Issuer) Common Stock (Title of Class of Securities) 53814L108 (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is

# # #

Exhibit 99.1 Livent Corporation 2929 Walnut Street Philadelphia, PA 19104 USA 215.299.6000 Livent.com News Release Media Contact: Juan Carlos Cruz +1.215.299.6170 [email protected] Investor Contact: Daniel Rosen +1.215.299.6208 [email protected] Livent Provides Revised 2019 Guidance and Additional Commentary on 2020 PHILADELPHIA, PA., January 7, 2020 - Livent Corporation (NYSE: LTH

Regulation FD Disclosure

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 7, 2020 LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorporation or organization)

LTHM / Livent Corp. 10-Q - Quarterly Report - 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2019 or o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number 001-38694 LIVENT CORPORATIO

-- Meets Third Quarter Adjusted EPS and Adjusted EBITDA Guidance -- -- Announces MoU for Multi-year Supply of Lithium Hydroxide to LG -- -- Reinforces Commitment to Existing Expansion Plans -- -- Provides First Look at Expected 2020 Volumes --

Exhibit 99.1 Livent Corporation 2929 Walnut Street Philadelphia, PA 19104 USA 215.299.6000 Livent.com News Release Media Contact: Juan Carlos Cruz +1.215.299.6170 [email protected] Investor Contact: Daniel Rosen +1.215.299.6208 [email protected] LIVENT RELEASES THIRD QUARTER 2019 RESULTS - Meets Third Quarter Adjusted EPS and Adjusted EBITDA Guidance - - Announces MoU for Multi-yea

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 5, 2019 LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorporation or organization)

LTHM / Livent Corp. 10-Q - Quarterly Report - 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2019 or o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number 001-38694 LIVENT CORPORATION (Ex

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 6, 2019 LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorporation or organization) (

Full-Year 2019

Exhibit 99.1 Livent Corporation 2929 Walnut Street Philadelphia, PA 19104 USA 215.299.6000 Livent.com For Release: Immediate Media Contact: Juan Carlos Cruz +1.215.299.6170 [email protected] Investor Contact: Daniel Rosen +1.215.299.6208 [email protected] Livent Announces Second Quarter 2019 Results Second Quarter Highlights • Revenue of $114 million • GAAP net income of $16 millio

LTHM / Livent Corp. S-8 - - S-8

As filed with the Securities and Exchange Commission on June 10, 2019 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 9, 2019 LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction (Commission (I.R.S. Employer of inco

Severance Agreement and Release by and between Thomas Schneberger and Livent Corporation, dated June 1, 2019 (Exhibit 10.1 to Amendment No. 1 to the Registrant's Report on Form 8-K dated May 9, 2019, filed on June 6, 2019)

SEVERANCE AGREEMENT AND RELEASE This Severance Agreement and Release (this “Agreement”) is made by and between Thomas Schneberger (“Employee”) and Livent Corporation (“Livent”).

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 9, 2019 LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorporation or organizat

LTHM / Livent Corp. 10-Q Quarterly Report 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2019 or o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number 001-38694 LIVENT CORPORATION (E

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 7, 2019 LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorporation or organization) (Com

Full - Year 2019

Exhibit 99.1 Livent Corporation 2929 Walnut Street Philadelphia, PA 19104 USA 215.299.6000 Livent.com For Release: Immediate Media Contact: Juan Carlos Cruz +1.215.299.6170 [email protected] Investor Contact: Rasmus Gerdeman +1.215.299.5924 [email protected] Livent Corporation Announces First Quarter 2019 Results First Quarter Highlights • Revenue of $98.3 million • GAAP net inc

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 1, 2019 LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorporation or organization) (Com

LTHM / Livent Corp. / VANGUARD GROUP INC Passive Investment

liventcorpdoc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 0 )* Name of issuer: Livent Corp Title of Class of Securities: Common Stock CUSIP Number: 53814L108 Date of Event Which Requires Filing of this Statement: March 29, 2019 Check the appropriate box to designate

LTHM / Livent Corp. LIVENT CORP. - DEF 14A

LIVENT CORPORATION - DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

LTHM / Livent Corp. / GLENVIEW CAPITAL MANAGEMENT, LLC Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* LIVENT CORPORATION (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 53814L108 (CUSIP Number) March 4, 2019 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule purs

LTHM / Livent Corp. FORM S-8

As filed with the Securities and Exchange Commission on March 5, 2019 Registration No.

LTHM / Livent Corp. / Fmc Corp - FORM SC 13G/A Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Amendment No. 1)* INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) Livent Corporation (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 53814L 108 (CUSIP Number) March 1, 2019 (Date

LTHM / Livent Corp. FORM S-8

As filed with the Securities and Exchange Commission on March 1, 2019 Registration No.

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 28, 2019 LIVENT CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-38694 82-4699376 (State or other jurisdiction of incorporation or organization

# # #

Exhibit 99.1 Livent Corporation 2929 Walnut Street Philadelphia, PA 19104 USA 215.299.6000 Livent.com News Release For Release: Immediate Media Contact: Juan Carlos Cruz +1.215.299.6170 [email protected] Investor Contact: Rasmus Gerdeman +1.215.299.5924 [email protected] Livent Corporation Announces Completion of Separation from FMC Corporation PHILADELPHIA, March 1, 2019 - Live

Form of Employee Option Award Agreement under the Livent Corporation Incentive Compensation and Stock Plan

NONQUALIFIED STOCK OPTION AWARD AGREEMENT UNDER THE LIVENT CORPORATION INCENTIVE COMPENSATION AND STOCK PLAN This NONQUALIFIED STOCK OPTION AWARD AGREEMENT (this “Agreement”) is made by and between Livent Corporation (the “Company”) and [Participant Name] (the “Participant”).

Livent Non-qualified Savings Plan Adoption Agreement, as of January 1, 2019 (Exhibit 10.21 to the 2018 Form 10-K)

ex1021lithiumnonqadoptio LIVENT NONQUALIFIED SAVINGS PLAN ADOPTION AGREEMENT TABLE OF CONTENTS 1.

Livent Corporation Executive Severance Plan, as of October 10, 2018

Livent Corporation Executive Severance Plan (Effective as of October 10, 2018) 1.Purpose. The purpose of the Plan is to assure the Company that it will have the continued dedication and the availability of objective advice and counsel from key executives of the Company, notwithstanding the possibility, threat or occurrence of a bid to take over control of the Company. The Board believes it is impe

Livent Non-qualified Savings Plan, as of January 1, 2019 (Exhibit 10.22 to the 2018 Form 10-K)

LIVENT NONQUALIFIED SAVINGS PLAN January 1, 2019 IMPORTANT NOTE This document has not been approved by the Department of Labor, Internal Revenue Service or any other governmental entity.

LTHM / Livent Corp. (Annual Report)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2018 or ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number 001-38694 LIVENT C

Livent Corporation Executive Severance Guidelines for Corporate Officers, as of October 10, 2018 (Exhibit 10.18 to the 2018 Form 10-K)

Livent Corporation Executive Severance Guidelines for Corporate Officers Background The intent of these severance guidelines (“Guidelines”) is to provide corporate officers of Livent Corporation (the “Company”) with reasonable transition benefits in the event of a termination of his or her employment without cause (other than in the context of a change in control or as a result of death, disability or normal retirement).

Subsidiaries of the Registrant

Exhibit 21 LIVENT CORPORATION SIGNIFICANT SUBSIDIARIES OF THE REGISTRANT The following is a list of the Company’s consolidating subsidiaries, as of December 31, 2018, except for certain subsidiaries of the Registrant which do not, in the aggregate, constitute a significant subsidiary as that term is defined in Rule 12b-2 under the Securities Exchange Act of 1934.

Livent Corporation Compensation Policy for Non-Employee Directors, as of December 11, 2018 (Exhibit 10.17 to the 2018 Form 10-K)

LIVENT CORPORATION COMPENSATION POLICY FOR NON-EMPLOYEE DIRECTORS (Effective December 11, 2018) Part I- GENERAL PROVISIONS 1.

Amended and Restated Employee Matters Agreement, dated as of February 4, 2019, by and between Livent Corporation and FMC Corporation (Exhibit 10.6 to the Registrant's Annual Report on Form 10-K filed on February 28, 2019 (the "2018 Form 10-K"))

AMENDED AND RESTATED EMPLOYEE MATTERS AGREEMENT by and between FMC CORPORATION and LIVENT CORPORATION Dated as of February 4, 2019 TABLE OF CONTENTS PAGE ARTICLE I DEFINITIONS Certain Definitions 1 ARTICLE II GENERAL ALLOCATION OF LIABILITIES; INDEMNIFICATION Allocation of Employee-Related Liabilities 8 Indemnification 9 ARTICLE III EMPLOYEES AND CONTRACTORS; EMPLOYMENT AND COLLECTIVE BARGAINING A

Form of Employee RSU Award Agreement under the Livent Corporation Incentive Compensation and Stock Plan

RESTRICTED STOCK UNIT AWARD AGREEMENT UNDER THE LIVENT CORPORATION INCENTIVE COMPENSATION AND STOCK PLAN This RESTRICTED STOCK UNIT AWARD AGREEMENT (this “Agreement”) is made by and between Livent Corporation (the “Company”) and [Participant Name] (the “Participant”).

LTHM / Livent Corp. / Fmc Corp - FORM SC 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) Livent Corporation (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 53814L 108 (CUSIP Number) December 31, 2018 (Date